Assessment of impact of the COVID-19 pandemic from the perspective of patients with rheumatic and musculoskeletal diseases in Europe: results from the REUMAVID study (phase 1).
Marco Garrido-CumbreraHelena Marzo-OrtegaLaura ChristenPedro Plazuelo-RamosDale WebbClare JacklinShantel IrwinLaurent GrangeSouzi MakriElsa Frazão MateusSerena MingollaKaty AntonopoulouSergio Sanz-GómezJosé Correa-FernándezLoreto CarmonaVictoria Navarro-CompánPublished in: RMD open (2021)
Throughout the first wave of the COVID-19 pandemic, patients with RMDs have experienced disruption in access to healthcare services, poor lifestyle habits and negative effects on their overall health, well-being and mental health. Furthermore, information on COVID-19 has not reached patients appropriately.
Keyphrases
- healthcare
- mental health
- end stage renal disease
- coronavirus disease
- ejection fraction
- health information
- newly diagnosed
- sars cov
- public health
- metabolic syndrome
- physical activity
- rheumatoid arthritis
- prognostic factors
- peritoneal dialysis
- type diabetes
- patient reported outcomes
- mental illness
- risk assessment
- patient reported
- health promotion
- human health
- clinical evaluation